HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today announced that it has filed its audited financial statements for the year ended December 31, 2007 in a Form 6-K with the U.S. Securities and Exchange Commission. The Company said that it will now turn its attention to the financial statements for 2008 and 2009.
